Third Point ASML Holding N.V. New York Registry Shares transactions over time
ASML
ASML Holding N.V. New York Registry Shares historical holders
total: 12
Transactions details
- Total transactions:
- 4
- New positions:
- 2
- Sold out:
- 1
- Added:
- 1
- Held since:
- 2026 Q1
- Held for:
- 2 quarters
- Latest activity:
- 2026 Q2
Daniel Loeb has been an institutional investor in ASML Holding N.V. New York Registry Shares (ASML) since 2024 Q2. According to 2026 Q2 report, Daniel Loeb holds 30,000 shares with a market value of roughly $59.61M representing 1.28% of their equity portfolio. The fund/company first acquired ASML in 2024 Q2, initially purchasing 80,000 shares. Daniel Loeb later completely sold out the position and reinvested in ASML again in 2026 Q1. Since the initial investment, Third Point has made 3 more transactions in this position.
Does Daniel Loeb still hold ASML?
Yes, Daniel Loeb continues to hold ASML Holding N.V. New York Registry Shares (ASML). According to their 2026 Q2 report, they maintain a position of 30,000 shares valued at approximately $59.61M, representing 1.28% of their equity portfolio.
When did Daniel Loeb first invest in ASML?
Daniel Loeb first invested in ASML Holding N.V. New York Registry Shares (ASML) in 2024 Q2 at the reported quarter-end price of $1,022.73 per share, acquiring 80,000 shares in their initial purchase.
What is Daniel Loeb's average cost basis for ASML?
Based on historical transaction data, Daniel Loeb's estimated cost basis for ASML Holding N.V. New York Registry Shares (ASML) is approximately $1,720.46 per share. This represents their average reported price* across all buy transactions.
Has Daniel Loeb reinvested in ASML after selling?
Yes, Daniel Loeb has shown renewed interest in ASML Holding N.V. New York Registry Shares (ASML). After completely selling their position, they reinitiated an investment in 2026 Q1, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $1,720.46
ASML transactions history by Third Point
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
1.28%
|
30,000
|
$1,986.87
|
$59,606,160
|
+150.00% (+18,000)
|
+0.77%
|
|
2026 Q1
|
0.76%
|
12,000
|
$1,320.83
|
$15,849,960
|
new
|
+0.76%
|
|
2024 Q3
|
0.00%
|
0
|
$1,022.73
|
|
-100% (-80,000)
|
-0.94%
|
|
2024 Q2
|
0.94%
|
80,000
|
$1,022.73
|
$81,818,400
|
new
|
+0.94%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.